| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| N-苄基-(9Z,12Z,15Z)-亚麻酰胺; N-Benzyllinolenamide | CFN90866 | 883715-18-2 | C25H37NO = 367.6 | 20mg | QQ客服：215959384 |
| 奴夫卡因; Procaine | CFN94479 | 59-46-1 | C13H20N2O2 = 236.31 | 20mg | QQ客服：215959384 |
| Neolinine; Neolinine | CFN96267 | 112515-37-4 | C23H37NO6 = 423.6 | 5mg | QQ客服：1413575084 |
| 3,4-二甲氧基苯甲酰胺; 3,4-Dimethoxybenzamide | CFN96268 | 1521-41-1 | C9H11NO3 = 181.2 | 5mg | QQ客服：215959384 |
| 去甲海罂粟碱盐酸盐; Norglaucine hydrochloride | CFN96271 | 39945-41-0 | C20H24ClNO4 = 377.9 | 5mg | QQ客服：3257982914 |
| 1-甲基-2-壬基喹啉-4(1H)-酮; 1-Methyl-2-nonylquinolin-4(1H)-one | CFN96290 | 68353-24-2 | C19H27NO = 285.4 | 5mg | QQ客服：2159513211 |
| 喹胺; Quinamine | CFN96295 | 464-85-7 | C19H24N2O2 = 312.4 | 5mg | QQ客服：1413575084 |
| 1-甲基-2-十一烷基喹啉-4(1H)-酮; 1-Methyl-2-undecylquinolin-4(1H)-one | CFN96296 | 59443-02-6 | C21H31NO = 313.5 | 5mg | QQ客服：3257982914 |
| Aglaxiflorin D; Aglaxiflorin D | CFN96299 | 269739-78-8 | C36H42N2O9 = 646.7 | 5mg | QQ客服：2056216494 |
| Aglain C; Aglain C | CFN96309 | 177468-85-8 | C36H42N2O8 = 630.7 | 5mg | QQ客服：215959384 |
| 康奎明; Conquinamine | CFN96329 | 464-86-8 | C19H24N2O2 = 312.4 | 5mg | QQ客服：1413575084 |
| (S)-金黄紫堇碱; Scoulerine | CFN96330 | 6451-73-6 | C19H21NO4 = 327.4 | 5mg | QQ客服：3257982914 |
| (-)-紫堇明; (-)-Corlumine | CFN96340 | 79082-64-7 | C21H21NO6 = 383.4 | 5mg | QQ客服：3257982914 |
| Aglain B; Aglain B | CFN96344 | 177262-32-7 | C36H42N2O8 = 630.7 | 5mg | QQ客服：2056216494 |
| 谷胱甘肽/5-L-谷氨酰-L-半胱氨酰甘氨酸; Glutathione | CFN96356 | 70-18-8 | C10H17N3O6S = 307.3 | 20mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)